Tag: treatment
The National Comprehensive Cancer Network (NCCN) has recently released a new guideline book for patients diagnosed with neuroendocrine tumors. With very readable language it discusses what neuroendocrine tumors are, how they are diagnosed, the various types of treatments that are…
On January 14, 2018, Dr. Thor Halfdanarson and Dr. A. Tuba Kendi from Mayo Clinic Rochester presented to Northwoods NETS. Dr. Tuba, a radiologist from Mayo, has been fronting the Gallium-68 PET/MRI scan center that has been helping detect and…
Advanced Accelerator Applications S.A. (AAA) has announced that the Food and Drug Administration (FDA), in the United States, has accepted and considered complete the resubmission of the New Drug Application (NDA) for its investigational drug lutetium Lu 177 dotatate (Lutathera). Lutathera…
It’s been a slow, sleepy summer… I’m eight weeks out from round two and happy to report, I am doing well. I won’t lie and say that it’s been all wine and roses the last few weeks. (Mmmm, wine and…
Woah! I wrote a few weeks ago and I thought I’d have plenty of time to blog before I went to Basel for round two and the time slipped away. I am already done with round two. My treatment date…
New results from the NETTER-1 study that compared Sandostatin LAR 60mg versus treatment with the novel peptide receptor radionuclide therapy (PRRT) Lutathera have been made available. These findings, released at the 2015 European Cancer Congress, show that for patients living with…
[embedplusvideo height=”400″ width=”584″ editlink=”http://bit.ly/Txp2YA” standard=”http://www.youtube.com/v/0YfLOUS61pg?fs=1″ vars=”ytid=0YfLOUS61pg&width=584&height=400&start=&stop=&rs=w&hd=0&autoplay=0&react=1&chapters=¬es=” id=”ep1361″ /] On May 18th, 2014, Nancy Teixeira, administrator from Wren Labs, talked to Northwoods NETS to talk about their unique biomarker that helps detect neuroendocrine cells in the blood sooner than any other…
On Sunday, March 9th, 2014, the Neuroendocrine Tumor Program team of Nebraska Medical Center presented their multidisciplinary approach to Northwoods NETS. Dr. Luciano Vargas gave a very informative speech that was a good primer about neuroendocrine tumors in general, as…
Summary: Robert Fine, MD, reported at a press conference held in advance of the 2014 Gastrointestinal Cancers Symposium (GICS), that the chemotherapy combination of capecitabine plus temozolomide either stalled disease progression or shrank tumors in 97% of patients whose disease had…
